Cargando…

Transcatheter arterial chemoembolization improves the resectability of malignant breast phyllodes tumor with angiosarcoma component: a case report

BACKGROUND: A giant phyllodes tumor of the breast is a rare fibroepithelial lesion, and its treatment is controversial. Many case reports have reported performing skin graft reconstruction after tumor excision. Chest wall resection may be required if the tumor has invaded the chest muscle layer. We...

Descripción completa

Detalles Bibliográficos
Autores principales: Kuo, Chih-Yu, Lin, Shing-Huey, Lee, Kuan-Der, Cheng, Sho-Jen, Chu, Jan-Show, Tu, Shih-Hsin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6660949/
https://www.ncbi.nlm.nih.gov/pubmed/31351458
http://dx.doi.org/10.1186/s12893-019-0562-0
_version_ 1783439388983689216
author Kuo, Chih-Yu
Lin, Shing-Huey
Lee, Kuan-Der
Cheng, Sho-Jen
Chu, Jan-Show
Tu, Shih-Hsin
author_facet Kuo, Chih-Yu
Lin, Shing-Huey
Lee, Kuan-Der
Cheng, Sho-Jen
Chu, Jan-Show
Tu, Shih-Hsin
author_sort Kuo, Chih-Yu
collection PubMed
description BACKGROUND: A giant phyllodes tumor of the breast is a rare fibroepithelial lesion, and its treatment is controversial. Many case reports have reported performing skin graft reconstruction after tumor excision. Chest wall resection may be required if the tumor has invaded the chest muscle layer. We speculated that transcatheter arterial chemoembolization (TACE) can improve the resectability of malignant phyllodes tumor of the breast without requiring skin grafting. The English literature contains only one case report similar to our experience. CASE PRESENTATION: We report a rare case of a 51-year-old woman who had a giant malignant phyllodes tumor with heterologous sarcomatous differentiation in her right breast. The tumor was 19.43 × 12.98 × 21.47 cm. Whole-body computed tomography (CT) and bone scan did not reveal distant metastasis. Chest magnetic resonance imaging showed chest wall tumor invasion. Considering that skin defects after mastectomy can be extensive, we administered four courses of chemoembolization in the 5 weeks before surgery (30 mg of epirubicin and embozene microspheres [400, 500, and 700 μm]/week). Each process was well tolerated, with no serious complications. Only fever and local pain at the tumor site were noted, and these symptoms resolved with time. The follow-up CT scan showed a 45% reduction in tumor volume. Therefore, simple mastectomy was performed without skin grafting reconstruction. Wound healing was satisfactory, and the patient was discharged 1 week after surgery. Pathological and immunohistochemistry (IHC) findings showed a malignant phyllodes tumor with an angiosarcoma component. Because of tumor invasion of the chest wall, we recommended the patient receive radiotherapy, but she refused. Two months after surgery, recurrence of the malignant phyllodes tumor with right axillary lymph node involvement and lung metastasis was confirmed. CONCLUSION: Initial surgical resection of giant phyllodes tumors is often challenging. For initial presentation with unresectable giant phyllodes tumor, we recommend to perform TACE prior to surgery. In our patient, preoperative TACE was effective and safe. If the tumor has invaded the chest wall, early radiotherapy after surgery may be recommended for preventing recurrence.
format Online
Article
Text
id pubmed-6660949
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-66609492019-08-01 Transcatheter arterial chemoembolization improves the resectability of malignant breast phyllodes tumor with angiosarcoma component: a case report Kuo, Chih-Yu Lin, Shing-Huey Lee, Kuan-Der Cheng, Sho-Jen Chu, Jan-Show Tu, Shih-Hsin BMC Surg Case Report BACKGROUND: A giant phyllodes tumor of the breast is a rare fibroepithelial lesion, and its treatment is controversial. Many case reports have reported performing skin graft reconstruction after tumor excision. Chest wall resection may be required if the tumor has invaded the chest muscle layer. We speculated that transcatheter arterial chemoembolization (TACE) can improve the resectability of malignant phyllodes tumor of the breast without requiring skin grafting. The English literature contains only one case report similar to our experience. CASE PRESENTATION: We report a rare case of a 51-year-old woman who had a giant malignant phyllodes tumor with heterologous sarcomatous differentiation in her right breast. The tumor was 19.43 × 12.98 × 21.47 cm. Whole-body computed tomography (CT) and bone scan did not reveal distant metastasis. Chest magnetic resonance imaging showed chest wall tumor invasion. Considering that skin defects after mastectomy can be extensive, we administered four courses of chemoembolization in the 5 weeks before surgery (30 mg of epirubicin and embozene microspheres [400, 500, and 700 μm]/week). Each process was well tolerated, with no serious complications. Only fever and local pain at the tumor site were noted, and these symptoms resolved with time. The follow-up CT scan showed a 45% reduction in tumor volume. Therefore, simple mastectomy was performed without skin grafting reconstruction. Wound healing was satisfactory, and the patient was discharged 1 week after surgery. Pathological and immunohistochemistry (IHC) findings showed a malignant phyllodes tumor with an angiosarcoma component. Because of tumor invasion of the chest wall, we recommended the patient receive radiotherapy, but she refused. Two months after surgery, recurrence of the malignant phyllodes tumor with right axillary lymph node involvement and lung metastasis was confirmed. CONCLUSION: Initial surgical resection of giant phyllodes tumors is often challenging. For initial presentation with unresectable giant phyllodes tumor, we recommend to perform TACE prior to surgery. In our patient, preoperative TACE was effective and safe. If the tumor has invaded the chest wall, early radiotherapy after surgery may be recommended for preventing recurrence. BioMed Central 2019-07-27 /pmc/articles/PMC6660949/ /pubmed/31351458 http://dx.doi.org/10.1186/s12893-019-0562-0 Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Case Report
Kuo, Chih-Yu
Lin, Shing-Huey
Lee, Kuan-Der
Cheng, Sho-Jen
Chu, Jan-Show
Tu, Shih-Hsin
Transcatheter arterial chemoembolization improves the resectability of malignant breast phyllodes tumor with angiosarcoma component: a case report
title Transcatheter arterial chemoembolization improves the resectability of malignant breast phyllodes tumor with angiosarcoma component: a case report
title_full Transcatheter arterial chemoembolization improves the resectability of malignant breast phyllodes tumor with angiosarcoma component: a case report
title_fullStr Transcatheter arterial chemoembolization improves the resectability of malignant breast phyllodes tumor with angiosarcoma component: a case report
title_full_unstemmed Transcatheter arterial chemoembolization improves the resectability of malignant breast phyllodes tumor with angiosarcoma component: a case report
title_short Transcatheter arterial chemoembolization improves the resectability of malignant breast phyllodes tumor with angiosarcoma component: a case report
title_sort transcatheter arterial chemoembolization improves the resectability of malignant breast phyllodes tumor with angiosarcoma component: a case report
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6660949/
https://www.ncbi.nlm.nih.gov/pubmed/31351458
http://dx.doi.org/10.1186/s12893-019-0562-0
work_keys_str_mv AT kuochihyu transcatheterarterialchemoembolizationimprovestheresectabilityofmalignantbreastphyllodestumorwithangiosarcomacomponentacasereport
AT linshinghuey transcatheterarterialchemoembolizationimprovestheresectabilityofmalignantbreastphyllodestumorwithangiosarcomacomponentacasereport
AT leekuander transcatheterarterialchemoembolizationimprovestheresectabilityofmalignantbreastphyllodestumorwithangiosarcomacomponentacasereport
AT chengshojen transcatheterarterialchemoembolizationimprovestheresectabilityofmalignantbreastphyllodestumorwithangiosarcomacomponentacasereport
AT chujanshow transcatheterarterialchemoembolizationimprovestheresectabilityofmalignantbreastphyllodestumorwithangiosarcomacomponentacasereport
AT tushihhsin transcatheterarterialchemoembolizationimprovestheresectabilityofmalignantbreastphyllodestumorwithangiosarcomacomponentacasereport